Markus Lucerna
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Atrial Fibrillation Management and Outcomes 10
-
- Angiogenesis and VEGF in Cancer 6
- Signaling Pathways in Disease 2
- Co-authors
- Paulus Kirchhof (10 shared papers)Ladislav Pecen (10 shared papers)Raffaele De Caterina (10 shared papers)Diana Mechtcheriakova (6 shared papers)Erhard Hofer (6 shared papers)Bernd R. Binder (5 shared papers)Matthias Clauss (5 shared papers)Gernot Schabbauer (4 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Heart (2 papers)Blood (2 papers)International Journal of Cardiology (2 papers)Cancer Research (2 papers)
- Partner nations
- GermanyItalyUnited Kingdom
In The Last Decade
Markus Lucerna
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 81
- Internal Medicine 110
- Cardiology and Cardiovascular Medicine 484
- Hematology 91
- Immunology and Allergy 45
- Cancer Research 100
Countries citing papers authored by Markus Lucerna
This map shows the geographic impact of Markus Lucerna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Lucerna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Lucerna more than expected).
Fields of papers citing papers by Markus Lucerna
This network shows the impact of papers produced by Markus Lucerna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Lucerna. The network helps show where Markus Lucerna may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Lucerna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 168 | |
| 2 | 2017 | 134 | |
| 3 | 2017 | 110 | |
| 4 | 2001 | 98 | |
| 5 | 2003 | 88 | |
| 6 | 2003 | 84 | |
| 7 | 2006 | 66 | |
| 8 | 2019 | 61 | |
| 9 | 2006 | 58 | |
| 10 | 2017 | 58 | |
| 11 | 2019 | 41 | |
| 12 | 2007 | 39 | |
| 13 | 2018 | 32 | |
| 14 | 2018 | 29 | |
| 15 | 2017 | 20 | |
| 16 | 2018 | 19 | |
| 17 | 2018 | 18 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Markus Lucerna
Markus Lucerna is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (10 papers), Angiogenesis and VEGF in Cancer (6 papers), Advanced Breast Cancer Therapies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Signaling Pathways in Disease (2 papers), Cell Adhesion Molecules Research (2 papers), Breast Cancer Treatment Studies (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Internal Medicine (110 citations), Cardiology and Cardiovascular Medicine (484 citations), Hematology (91 citations), Immunology and Allergy (45 citations) and Cancer Research (100 citations). Markus Lucerna has collaborated with scholars based in Germany, Italy and United Kingdom. Frequent co-authors include Paulus Kirchhof, Ladislav Pecen, Raffaele De Caterina, Diana Mechtcheriakova, Erhard Hofer, Bernd R. Binder, Matthias Clauss, Gernot Schabbauer, Giuseppe Patti and Jolanta M. Siller‐Matula. Their work appears in journals such as Journal of Biological Chemistry, Heart, Blood, International Journal of Cardiology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.